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Figure 1. Figure 2.
3D view of the malcoaptation of the tricuspid valve leaflets 
caused by a pacemaker lead.
Apical four chamber view of the malcoaptation of the tricus-
pid valve leaflets caused by a pacemaker lead.
Implantable device leads can cause tricuspid regurgitation (TR) when they interfere with leaflet motion. Patients may 
present with clinical symptoms of right-sided congestive heart failure (jugular venous distention, pulsatile liver, peripheral 
edema), although many are asymptomatic. The detection of severe tricuspid regurgitation by echocardiography may be 
missed because of acoustic shadowing from the pacemaker wires and suboptimal visualization of the regurgitant jet.1-3
The aim of this study was to present the various mechanisms through which ventricular leads may cause TR in real-life 
cases detected by echocardiography. 
We describe five patients with new or worsening preexisting TR after the implantation of one or more right ventricular 
leads, their clinical presentation, diagnosis and treatment (Figure 1, Figure 2). The mechanisms of TR include lead adher-
ence to the leaflets due to fibrosis and scar formation causing incomplete valve closure, valve obstruction caused by a 
lead placed in between leaflets, lead entrapment in the tricuspid valve apparatus, valve perforation or laceration by the 
pacemaker lead and annular dilatation of the valve. 
ConClusion: TR should be suspected in patients with implantable device leads who develop new onset right heart 
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